Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide

In the coronavirus disease 19 (COVID-19) pandemic era, the number of haploidentical hematopoietic cell transplantations (HCTs) with peripheral blood (PB) grafts increased significantly compared with HCTs with bone marrow (BM) grafts, which may be associated with adverse outcomes. We compared outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Rohtesh S., Saliba, Rima M., Alsfeld, Leonard C., Jorgensen, Jeffrey L., Wang, Sa A., Anderlini, Paolo, Al-Atrash, Gheath, Bashir, Qaiser, Ciurea, Stefan O., Hosing, Chitra M., Im, Jin S., Kebriaei, Partow, Khouri, Issa, Marin, David, Nieto, Yago, Olson, Amanda, Oran, Betul, Popat, Uday R., Qazilbash, Muzaffar H., Ramdial, Jeremy, Rondon, Gabriela, Saini, Neeraj, Srour, Samer A., Rezvani, Katayoun, Shpall, Elizabeth J., Champlin, Richard E., Alousi, Amin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504778/
https://www.ncbi.nlm.nih.gov/pubmed/34537419
http://dx.doi.org/10.1016/j.jtct.2021.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504778/
https://www.ncbi.nlm.nih.gov/pubmed/34537419
http://dx.doi.org/10.1016/j.jtct.2021.09.003

Ejemplares similares